MRNA Moderna Inc
Company Analysis
Latest News
Moderna Flu Vaccine Outperforms Standard Shots, Sustaining Immune Response for Six Months
Moderna’s investigational flu vaccine, mRNA-1010, produces a broader and more durable antibody response than conventional shots. A study in Nature Immunology...
Moderna Alleges Breach of Agreement in COVID-19 Vaccine Patent Lawsuit with CureVac
Moderna countered a patent-infringement lawsuit from CureVac. Moderna claims the legal action violates a prior agreement between the two biotech firms. In a...
Moderna Plunges 7%, Following $3.6 Million Insider Sale
Moderna, Inc. (MRNA) shares fell 7.51% in a single trading session. The stock price closed at $63.15. President Stephen Hoge sold approximately $3.6 million...
🔴 Moderna is trading 4.3% down today as Sanofi files new patent infringement lawsuits
Moderna is trading 4.3% down at $65.32 following news that Sanofi has filed new patent infringement lawsuits against the company in U.S. federal court. •...
Moderna Stock Tumbles Over 10% Following JPMorgan Sell Rating
Moderna (MRNA) shares fell sharply on Friday, July 10, declining by as much as 12%. The drop was primarily triggered after JPMorgan reaffirmed its "Sell"...
🔴 Moderna is trading 10.2% down
Moderna is trading at $68.77, down 10.2% from a comparison close of $76.56 during regular trading. This is a price-action follow-up, so a separate catalyst may...
🔴 Moderna is trading 7.2% down today after a sharp multi-week rally and valuation concerns
Moderna is trading 7.2% down at $71.05 following a sharp multi-week rally as concerns linger that its valuation has outpaced underlying fundamentals. • Shares...
🔴 MRNA extends move to 6.1% down
MRNA is trading at $74.94, down 6.1% versus the comparison close of $79.77 during regular trading. This is a price-movement alert; no separate company-specific...
🔴 MRNA is trading 4.1% down today on a technical pullback and broader risk-off sentiment
MRNA is trading 4.1% down at $76.53 as the stock undergoes a technical pullback following a sharp rally over the past week. • The move appears to be a...
🔴 MRNA is trading 4.1% down today in a pullback from recent strength
MRNA is trading 4.1% down at $78.45 as the stock pulls back from a sharp run-up over the prior week. • There is no clear company-specific news catalyst for...
🟢 MRNA makes sharp 11.1% jump
MRNA is trading at $80.55, up 11.1% versus the comparison close of $72.50 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 MRNA is trading 5.1% up today driven by post-earnings repricing and pipeline optimism
MRNA is trading at $76.20 (+5.11%) as buyers extend the recent post-earnings rally. A recent analysis says the move is tied to Moderna’s first-quarter update,...
🟢 MRNA extends move to 5.4% up
MRNA is trading at $73.81, up 5.4% versus the comparison close of $70.03 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 MRNA continues rally on broader pipeline optimism and short squeeze
MRNA is trading 4% up at $72.84, extending a significant rally fueled by multiple catalysts. Investors are responding to recent positive regulatory momentum...
🟢 MRNA is trading 4.2% up today on regulatory progress for its flu vaccine
MRNA is trading 4.2% up now at $72.59, extending a sharp multi-day rally driven by regulatory progress on its mRNA flu vaccine, mFlusiva. • The move follows...
🟢 MRNA makes sharp 12.7% jump
MRNA is trading at $67.32, up 12.7% versus the comparison close of $59.75 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 MRNA is trading 5.5% up today after detailing expansion into autoimmune and cancer therapies
MRNA is trading 5.5% higher at $63.01 after investors reacted positively to the company's Science Day presentation detailing its expansion into autoimmune and...
Moderna expands into autoimmune and cancer therapies with new CAR-T program
Moderna hosted its Science Day on June 25, 2026, to detail updates to its research and early development pipeline. The company is moving mRNA-6007, a new in...
🟢 MRNA extends move to 6.7% up
MRNA is trading at $63.30, up 6.7% versus the comparison close of $59.34 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 MRNA is trading 4.8% up today, rebounding on continued FDA flu vaccine panel optimism
MRNA is trading 4.8% up at $62.17 as it rebounds from yesterday's sharp sell-off on continued optimism surrounding its flu vaccine pipeline. • The stock is...